Literature DB >> 33742319

POU1F1 mutations in combined pituitary hormone deficiency: differing spectrum of mutations in a Western-Indian cohort and systematic analysis of world literature.

Swati Jadhav1, Chakra Diwaker2, Anurag R Lila3, Jugal V Gada4, Shantanu Kale2, Vijaya Sarathi5, Puja M Thadani2, Sneha Arya2, Virendra A Patil2, Nalini S Shah2, Tushar R Bandgar2.   

Abstract

CONTEXT: POU1F1 mutations are prevalent in Indian CPHD cohorts. Genotype-phenotype correlation is not well-studied. AIM: To describe phenotypic and genotypic spectrum of POU1F1 mutations in our CPHD cohort and present systematic review as well as genotype-phenotype analysis of all mutation-positive cases reported in world literature.
METHODS: Retrospective study of POU1F1 mutation-positive patients from a western-Indian center. PRISMA guidelines based pubmed search of published literature of all mutation-positive patients.
RESULTS: Our cohort had 15 POU1F1 mutation-positive patients (9 index, 6 relatives). All had severe GH, TSH and prolactin deficiencies (GHD, TSHD and PD). TSHD was diagnosed earliest followed by GHD (median ages: TSHD-6 months, GHD-3 years), while PD was more variable. Two sisters had central precocious puberty at 7 years of age. Pubic hair was deficient in all post-pubertal patients (females: P1-P2, males: P3-P4). Splice-site/intronic/frameshift mutations were most common, while missense/nonsense mutations were less frequent (33%). Review of world literature yielded 114 patients (82 index patients) from 58 studies. GHD was present in all patients. TSHD was spared in 12.5% and PD in 4.4% patients. Missense/nonsense mutations accounted for 75% of spectrum. Phenotype-genotype analysis revealed higher mean peak-GH levels (1.1 vs 0.2 ng/ml, p = 0.008) and lower prevalence of anterior-pituitary hypoplasia (63.6% vs 86.3%, p = 0.03) in patients with heterozygous than homozygous and compound heterozygous mutations.
CONCLUSIONS: We present largest series of POU1F1 mutation-positive patients. Precocious puberty and defective pubarche are lesser-appreciated phenotypic features. Our mutation spectrum is different from that of world literature. Patients with heterozygous mutations have milder phenotype.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CPHD-Combined Pituitary Hormone Deficiency; Genotype–phenotype analysis; POU1F1; Puberty

Mesh:

Substances:

Year:  2021        PMID: 33742319     DOI: 10.1007/s11102-021-01140-9

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  36 in total

1.  DWARF, A NEW MENDELIAN RECESSIVE CHARACTER OF THE HOUSE MOUSE.

Authors:  G D Snell
Journal:  Proc Natl Acad Sci U S A       Date:  1929-09-15       Impact factor: 11.205

2.  Homozygous microdeletion of the POU1F1, CHMP2B, and VGLL3 genes in chromosome 3--a novel syndrome.

Authors:  Galia Gat-Yablonski; Rachel Frumkin-Ben David; Meytal Bar; Olga Potievsky; Moshe Phillip; Liora Lazar
Journal:  Am J Med Genet A       Date:  2011-08-03       Impact factor: 2.802

3.  Crystal structure of the RNA-binding domain of the U1 small nuclear ribonucleoprotein A.

Authors:  K Nagai; C Oubridge; T H Jessen; J Li; P R Evans
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

Review 4.  Combined pituitary hormone deficiency: role of Pit-1 and Prop-1.

Authors:  R W Pfäffle; O Blankenstein; S Wüller; H Kentrup
Journal:  Acta Paediatr Suppl       Date:  1999-12

5.  Two novel mutations in acid α-glucosidase gene in two patients with Pompe disease.

Authors:  Ayca Aykut; Huseyin Onay; Melis Kose; Ebru Erbas Canda; Emin Karaca; Mahmut Coker; Ferda Ozkinay
Journal:  J Pediatr Endocrinol Metab       Date:  2014-11       Impact factor: 1.634

6.  Joint laxity in homozygotes for severe POU1F1 mutations.

Authors:  Hanan E Shamseldin; Sateesh Maddirevula; Amira Nabil; Saeed Al-Fadhil; Saeed Al Tala; Fowzan S Alkuraya
Journal:  Am J Med Genet A       Date:  2016-08-19       Impact factor: 2.802

7.  The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency.

Authors:  F de Zegher; F Pernasetti; C Vanhole; H Devlieger; G Van den Berghe; J A Martial
Journal:  J Clin Endocrinol Metab       Date:  1995-11       Impact factor: 5.958

Review 8.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

9.  Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene.

Authors:  K Tatsumi; K Miyai; T Notomi; K Kaibe; N Amino; Y Mizuno; H Kohno
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

View more
  2 in total

1.  Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events.

Authors:  Chakra Diwaker; Puja Thadani; Saba Samad Memon; Vijaya Sarathi; Anurag Ranjan Lila; Sneha Arya; Brijesh Krishnappa; Manjiri Karlekar; Virendra A Patil; Nalini Shah; Tushar Bandgar
Journal:  Pituitary       Date:  2022-06-24       Impact factor: 3.599

2.  High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency.

Authors:  Peter Gergics; Cathy Smith; Hironori Bando; Alexander A L Jorge; Denise Rockstroh-Lippold; Sebastian A Vishnopolska; Frederic Castinetti; Mariam Maksutova; Luciani Renata Silveira Carvalho; Julia Hoppmann; Julián Martínez Mayer; Frédérique Albarel; Debora Braslavsky; Ana Keselman; Ignacio Bergadá; Marcelo A Martí; Alexandru Saveanu; Anne Barlier; Rami Abou Jamra; Michael H Guo; Andrew Dauber; Marilena Nakaguma; Berenice B Mendonca; Sajini N Jayakody; A Bilge Ozel; Qing Fang; Qianyi Ma; Jun Z Li; Thierry Brue; María Ines Pérez Millán; Ivo J P Arnhold; Roland Pfaeffle; Jacob O Kitzman; Sally A Camper
Journal:  Am J Hum Genet       Date:  2021-07-15       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.